Home | Chinese | ENGLISH
Home > News > Industry News  
Efficient bulk drugs pulled the market

    Foreign consulting firm survey, the global API market total sales in 2010 reached 101.08 billion U.S. dollars in 2011 amounted to about $ 110 billion, an increase of 8.15%. Listed since 2000, a large number of best-selling bulk drugs patents have expired and generic drugs, it is expected that the international API market will continue to maintain a growth rate of 7 percent to 8 percent in the next five years.

   North America is the world"s largest raw material medicine market, accounting for 58% of the international API market; Europe is the world"s second largest pharmaceutical raw materials after the North America market, accounting for 29%; Japan while homegrown ; other countries and regions, only the remaining 13% of the total bulk drugs market share. Why the downturn in the economy of Europe and the United States and other Western countries and periods, the world"s pharmaceutical raw materials market was able to continue to maintain growth momentum? Western economists believe that this situation with a large number of top-selling drugs patent expires after a large number of cheaper generic bulk drugs market is flooded with these drugs are mostly annual sales of over $ 2,000,000,000 of products, after the loss of patent protection as the manufacturers of generic drugs prey, pushed up the growth of the international API market related products.

   Bulk drugs market has been rapid growth in the past few years, another factor that can not be ignored is the advent of highly potent APIs (HPAPI) and the rapid increase in the amount of.